| Bioactivity | Influenza A NP (383-391) (HLA-B27) is a peptide sequence derived from tetanus toxin. Influenza A NP (383-391) (HLA-B27) is a broadly immunogenic CD4+ T helper cell epitope that enhances CD8+ cytotoxic T lymphocyte (CTL) responses. Influenza A NP (383-391) (HLA-B27) can be used in breast cancer research[1]. |
| CAS | 126779-14-4 |
| Sequence | Phe-Asn-Asn-Phe-Thr-Val-Ser-Phe-Trp-Leu-Arg-Val-Pro-Lys-Val-Ser-Ala-Ser-His-Leu-Glu |
| Shortening | FNNFTVSFWLRVPKVSASHLE |
| Formula | C117H172N30O30 |
| Molar Mass | 2478.80 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Y Xie, et al. "Potent CD4+ T-cell epitope P30 enhances HER2/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responses." Cancer Gene Therapy 20.10 (2013): 590-598. |
Influenza A NP (383-391) (HLA-B27)
CAS: 126779-14-4 F: C117H172N30O30 W: 2478.80
Influenza A NP (383-391) (HLA-B27) is a peptide sequence derived from tetanus toxin. Influenza A NP (383-391) (HLA-B27)
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.